Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

Clinical trial NCT00153998 · COMPLETED

Trial details

NCT number: NCT00153998
Sponsor: Technische Universität Dresden
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Liver Metastases

Start date: 2004-11-01
Primary completion: 2008-03-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.